While gastrointestinal side effects are well-documented, some patients report skin-related concerns, including sensitive skin
Cost-effectiveness outcomes were tested for a range of liraglutide price reductions, and these showed that oral semaglutide was considered dominant in every scenario with a 20% reduction applied to the liraglutide price, and dominant in all-but-one scenario with a 30% reduction applied to the liraglutide price (Fig
For individuals with a body mass index (BMI) of 30 or higher, or those with a BMI of 27 or higher who have weight-related health issues, Semaglutide can be an effective weight loss aid
Several medical conditions and patient characteristics may contraindicate semaglutide use or require careful consideration and monitoring
Malyszczak A, Przezdziecka-Dolyk J, Szydelko-Pasko U, Misiuk-Hojlo M
Glucagon-like peptide 1 (GLP-1) receptor agonists, commonly referred to as GLP-1 drugs, are widely recognized for their use in managing type 2 diabetes and supporting weight loss
